Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 260
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
The Problems We Will Be Lucky to Have
Pα+ Psychedelic Bulletin #234: Psychedelics After the Midterms; FDA Answers House Psychedelics Caucus; ICER to Review Compass’ Psilocybin; Terran v. Compass Gets Trial Date
Is It Worth It? What Colorado’s Early Experience With Regulated Psychedelic Care Has the Field Asking, and What To Do About It
Compass Says NDA Will Be Filed Within Two Weeks, Declines to Comment on Usona
Podcast: Usona Files Psilocybin Application, We Review 610 Comments Submitted to FDA, and FDA Approves NRx’s Generic Ketamine
PTSF70 – Depth Psychology, The Reach of the DEA, and Progress...
Psychedelics, Religion, and the DEA’s Quest for Soul
PT255 – Jasmine Virdi – Conservation, Covid, and Neurodivergence
Psychedelic Medicine Virtual Symposium – 8/28, 9/11, 9/25
Optimi Health Joins First Psychedelic Exchange Traded Fund
Ian Burnstein Joins Wesana Health Advisory Board
Silo Wellness Announces Approval for Trading on the OTCQB Under Symbol...
Active vs. Passive Coping Distinguishes Antidepressants and Psychedelics
Psychedelic Research Bulletin: June 2021
PsyBio Therapeutics Augments Intellectual Property Portfolio with Filing of Next Novel...
Load more